Evaluation of anti-cancer stem cell activity of the anti-DLL4 antibody MEDI0639 in a phase I clinical trial of SCLC.

e20093Background: Small-cell lung cancer (SCLC) is a very aggressive lung cancer with a high metastatic potential. Many patients with SCLC initially respond to standard-of-care therapy but have rap...